NASARUPLASE GAMMA
UNII 66522BCB6P

Substance Identification & Data

This profile provides standardized clinical and technical data for Nasaruplase Gamma, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 66522BCB6P.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2647419-93-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
66522BCB6P
CAS Registry Number
2647419-93-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
NASARUPLASE GAMMA
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12267
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nasaruplase Gamma. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

NASARUPLASE GAMMA

Common Names & Synonyms

HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR (U-PLASMINOGEN ACTIVATOR, UPA, PLAU, EC:3.4.21.73), SINGLE-CHAIN PRO-PROTEIN (PRO-UROKINASE), PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-DG44, CLONE 8-93, GLYCOFORM GAMMA
NASARUPLASE GAMMA [INN]
PRO-UROKINASE-TYPE PLASMINOGEN ACTIVATOR (RECOMBINANT HUMAN LTI-01)